Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Psa2g0520 | ATGCAGGTTTTCTGGTTGATGATGTTGTTGTTGTTGATGGTGAAAACTGTATTGGGGAATTCAGATATTGATGCACTTCTTGAACTCAAGAAGGGTATTCAAAGTGACCCTTTTGGATTAGTTCTTAATTCTTGGGATTCTAACTCATTGGACTCTAATGGATGTGCTCAAAACTGGTATGGAGTATTCTGTAGTGATGGAAGTGTTGTATCTATCACTCTTGACAATGCCGGTTTGGTTGGCGAGTTTAATTTTGTTGCAGTTAGTTCTCTTCCAATGCTGCGTAATTTGACAGTTGTAAACAATAGTTTCACTGGAAGTATGTCACGAATCGCTCCAATGAAATCGCTTAAGTTTCTTGATTTGTCTCTCAACAAGTTCACCGGCTTGTTTCCTTCTACATTCGTCGAATCGCGTGGTTTATTGTATGTGAATCTCTCTTCGAATGAATTTAGTGGTACTCTCCCGAACGTGTTTCACAAACTTGAGGAGTTGAAGTATTTAGATATTCGCGGTAATAACTTTTCTGGTGATGTTATGCATGTATTTTATCAGATGGGAAGTGTGTTACATGTTGATTTAAGCAACAACAGGTTTTCCGGTGCGTTGGATTTAGGACTTGGAGATGTTTCGTTTCTGTTCTCGATTCAATATCTAAATGCTAGCCATAATTCGTTGACGGGTGAGCTATTTGCTCATGATGGTATGCCGTACCTTGATAATTTAGAGGTCTTCGATGCTAGTAATAACCAGATTGTTGGTAATATACCTTCCTTCGCATTTGTTGTATCGCTGAGGATTCTTCGGCTCGAATGCAATCGGTTGACAGGTTCCCTGCCAGAAACTTTGTTGAAGGAAAGTTCAATGATGTTGTCTGAACTGGATCTTAGTCAAAACAAGCTTGAAGGTTCCATTGGAAGCATTACTTCATTGACTCTAAGGAAGCTTAACATATCTTCAAACAAGTTATCAGGCTCATTACCTTTCAAAGTAGGACACTGTGCCATTATAGATTTGAGCAACAACATGTTGTTTGGTAACTTGTCAAGGATCAAGAATTGGGGAAACTATGTAGAAGTTATTCATCTTAGTACAAACTCGTTATCCGGAACGCTTCCGAACGAAACCTGTCAGTTTTTAAGGTTAACTTCACTTAAGGTATCCAATAACTCATTGGAAGGTTTTCTGCCACCAGTTTTAGGAACATTTCCAGAACTAAAAGAGATTGATCTGAGTCTCAACCGGCTTTCTGGGTTCCTCCTACCGACCCTTCTCGCCTCGACCAAGTTGACTACTCTTAATCTCTCAAACAATAACTTTTCTGGACCAGTTCCTTTTCAACTTCCAAGTACTTCATTGGTTTCTTCCGAAAATCTTAGTTTGACATCGCTTGATCTTTCGAACAATAACTTGAATGGAACTCTTTCTCCAAAAATTACGGAGCTTCATAATTTGGAGTATCTTTACCTATGTAACAACAAATTGGAAGGTAGTATTCCTAATGATCTTTCAGATGAATTAAGAGGATTCAATGTGTCCTTTAACAATTTTTCTGGTGTTGTACCTGATAAATTATTGCAGTTTCCTGAATCAGCATTTCATCCAGGAAATCCTATGCTGATATATCCGAATTCTCGGTTATCGCCTAAAGATAGTTCAAATTCCATCCTAGGTTCGAGGTCACATAAGAAAATTTTCACTAGGAGTGTCTTGATTACATGTTTGGTTACTGGTGCTTCTGTGATGGCTATTATGGCTGCAACGATTTTTTATAGGATTCGTCAGAAAAAAGAAAGGGATTCTAAACAAGACGCGACCGCAAGTGACATTGTCCAAGAGAGTAGTTCTCCATCGAAGAGAAGAAACTTGGAATCTTTGCAGCCTTCTCGAAGTGATGATACCGAAAACATTCATCCAACTGTAAAGAAGCCTGAACATCCTGAATTAGTTAAGAACGAGGAAGGAGCGTCTTCGCCAATGTCTATTTTATCGGCTTCGAATCCTTCACCTTCTACTAGCCGTCAGTTCGAGAATCCTAGTTCGCTCAATGTATCATCTCCGGATAAACTGGTCGGGGACTTACATCTATTCGATGGATCGTTGATGTTAACTGCAGAAGAACTTTCGCGTGCTCCGGCTGAAGTTATCGGTAGGAGCTGTCATGGAACACTCTACAAAGCTACACTTGAATCTGGTCATGTTTTGGCTGTCAAATGGTTAAGAGAAGGAATAACTAAAGGAAAAAAGGAGTTGGCAAGAGAAATCAAGAAACTCGGGACGATCAAGCATCCGAGTTTGGTTTCGTTTCTCGGTTGCTACCTCGGGCCAAAGGAGCATGAGAGACTGATTATATCAAATTTCATGAATGCTTATTCTTTGGACATTTATCTCCATGAGTCTGATAGAAGAAATCTCGATCCTTTGTCTCTTGATGAAAGGCTCAGGGTGGCCGTAGAAGTGGCGCGATGTCTACTCTACCTACACACCGAGAAAGCCATACCTCATGGCAATCTCAAATCCACAAACATTCTACTAGAAACTCCAAACAGAAATGCCTTGCTCACTGACTACACCCTGCATCGAATACTTACCGCGGCTGGCACTTCCGAGCAAGTTCTGAATGCAGGCGCGCTTGGTTACCGCCCGCCCGAGTTCGCTAGATCAACCAAACCAAGCCCTTCGTTAAAGAGCGACGTCTACGCGTTCGGAGTCGTCTTGTTAGAGCTCCTAACAGGAAGAAAGTCAGGAGAAATCGTGTCGGGGATTCCTGGCGTGGTTGAACTTACCGAATGGGTGAGATTCTTAGTCGAACGAGATCGCTCTAACCAATGCATTGAAAAGTCCCTTGCAGAAGGATCATCTATGATTCTTGATGATATGCTAAAAGTGGCTATAAGATGCATTCTTCCAGCATCTGAAAGGCCTGACATGAAAACAGTCTTTGAAGATCTTTCAACAATAAGGGAGAGTTGA | 2973 | 0.41 | MQVFWLMMLLLLMVKTVLGNSDIDALLELKKGIQSDPFGLVLNSWDSNSLDSNGCAQNWYGVFCSDGSVVSITLDNAGLVGEFNFVAVSSLPMLRNLTVVNNSFTGSMSRIAPMKSLKFLDLSLNKFTGLFPSTFVESRGLLYVNLSSNEFSGTLPNVFHKLEELKYLDIRGNNFSGDVMHVFYQMGSVLHVDLSNNRFSGALDLGLGDVSFLFSIQYLNASHNSLTGELFAHDGMPYLDNLEVFDASNNQIVGNIPSFAFVVSLRILRLECNRLTGSLPETLLKESSMMLSELDLSQNKLEGSIGSITSLTLRKLNISSNKLSGSLPFKVGHCAIIDLSNNMLFGNLSRIKNWGNYVEVIHLSTNSLSGTLPNETCQFLRLTSLKVSNNSLEGFLPPVLGTFPELKEIDLSLNRLSGFLLPTLLASTKLTTLNLSNNNFSGPVPFQLPSTSLVSSENLSLTSLDLSNNNLNGTLSPKITELHNLEYLYLCNNKLEGSIPNDLSDELRGFNVSFNNFSGVVPDKLLQFPESAFHPGNPMLIYPNSRLSPKDSSNSILGSRSHKKIFTRSVLITCLVTGASVMAIMAATIFYRIRQKKERDSKQDATASDIVQESSSPSKRRNLESLQPSRSDDTENIHPTVKKPEHPELVKNEEGASSPMSILSASNPSPSTSRQFENPSSLNVSSPDKLVGDLHLFDGSLMLTAEELSRAPAEVIGRSCHGTLYKATLESGHVLAVKWLREGITKGKKELAREIKKLGTIKHPSLVSFLGCYLGPKEHERLIISNFMNAYSLDIYLHESDRRNLDPLSLDERLRVAVEVARCLLYLHTEKAIPHGNLKSTNILLETPNRNALLTDYTLHRILTAAGTSEQVLNAGALGYRPPEFARSTKPSPSLKSDVYAFGVVLLELLTGRKSGEIVSGIPGVVELTEWVRFLVERDRSNQCIEKSLAEGSSMILDDMLKVAIRCILPASERPDMKTVFEDLSTIRES* | 991 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Psa2g0520 | 990 | Gene3D | Transferase(Phosphotransferase) domain 1 | 788 | 990 | - | - | |
Psa2g0520 | 990 | SMART | LRR_typ_2 | 262 | 286 | IPR003591 | - | |
Psa2g0520 | 990 | SMART | LRR_typ_2 | 482 | 506 | IPR003591 | - | |
Psa2g0520 | 990 | SMART | LRR_typ_2 | 114 | 137 | IPR003591 | - | |
Psa2g0520 | 990 | Pfam | Leucine rich repeat | 116 | 175 | IPR001611 | GO:0005515 | |
Psa2g0520 | 990 | PANTHER | OS07G0626500 PROTEIN | 1 | 988 | - | - | |
Psa2g0520 | 990 | Gene3D | Ribonuclease Inhibitor | 19 | 183 | IPR032675 | - | |
Psa2g0520 | 990 | MobiDBLite | consensus disorder prediction | 601 | 684 | - | - | |
Psa2g0520 | 990 | MobiDBLite | consensus disorder prediction | 607 | 634 | - | - | |
Psa2g0520 | 990 | Pfam | Leucine Rich repeat | 427 | 442 | IPR001611 | GO:0005515 | |
Psa2g0520 | 990 | Gene3D | Ribonuclease Inhibitor | 184 | 265 | IPR032675 | - | |
Psa2g0520 | 990 | Gene3D | Ribonuclease Inhibitor | 453 | 532 | IPR032675 | - | |
Psa2g0520 | 990 | Gene3D | Ribonuclease Inhibitor | 266 | 333 | IPR032675 | - | |
Psa2g0520 | 990 | Gene3D | Phosphorylase Kinase; domain 1 | 702 | 787 | - | - | |
Psa2g0520 | 990 | PANTHER | LEUCINE-RICH REPEAT PROTEIN KINASE FAMILY PROTEIN | 1 | 988 | - | - | |
Psa2g0520 | 990 | MobiDBLite | consensus disorder prediction | 657 | 684 | - | - | |
Psa2g0520 | 990 | ProSiteProfiles | Leucine-rich repeat profile. | 290 | 312 | IPR001611 | GO:0005515 | |
Psa2g0520 | 990 | SUPERFAMILY | Protein kinase-like (PK-like) | 714 | 984 | IPR011009 | - | |
Psa2g0520 | 990 | ProSiteProfiles | Protein kinase domain profile. | 710 | 987 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Psa2g0520 | 990 | Pfam | Protein tyrosine and serine/threonine kinase | 714 | 922 | IPR001245 | GO:0004672|GO:0006468 | |
Psa2g0520 | 990 | SUPERFAMILY | L domain-like | 238 | 524 | - | - | |
Psa2g0520 | 990 | MobiDBLite | consensus disorder prediction | 635 | 652 | - | - | |
Psa2g0520 | 990 | Pfam | Leucine rich repeat N-terminal domain | 20 | 65 | IPR013210 | - | |
Psa2g0520 | 990 | Pfam | Leucine Rich Repeat | 484 | 504 | IPR001611 | GO:0005515 | |
Psa2g0520 | 990 | Gene3D | Ribonuclease Inhibitor | 334 | 452 | IPR032675 | - | |
Psa2g0520 | 990 | SUPERFAMILY | L domain-like | 22 | 303 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Psa2g0520 | Psa-Chr2 | 23981653 | 23985784 | Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Psa2g0520 | 54 | 987 | Receptor kinase-like Gene Family | AT5G07280 | 29.120 | 1.33e-75 | 269 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-III | Psa2g0520 | PK_Tyr_Ser-Thr | 2.6e-27 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Psa2g0520 | - | - | cam:101512473 | 1447.18 |